Molecular studies of matrix metalloproteinases and tissue inhibitors of metalloproteinases in equine joints

Equine osteoarthritis: a brief review of the disease and its causes

Degenerative joint diseases, such as osteoarthritis, adversely impact the health of the equine athlete as well as the economics of the equine industry. Our understanding of the aetiology of osteoarthritis, although not nearly exhaustive, has increased substantially in recent years. Molecules, including cytokines, inflammatory mediators, and metalloproteinases, have been identified and associated with the progression of joint disease. Several factors, including trauma to the joint, immobilization, conformation, shoeing, and ageing, have been linked with osteoarthritis. Our continued efforts into elucidating critical biological mediators and risk factors, coupled with better chondroprotective therapies and diagnostic tools, should facilitate our ability to maintain the skeletal health of the equine athlete

Differential regulation of gelatinases by transforming growth factor beta-1 in normal equine chondrocytes

OBJECTIVE

Cartilage destruction in osteoarthritis (OA) is associated with increased levels of several matrix metalloproteinases (MMPs), including the gelatinases MMP-2 and MMP-9. While increases in some MMPs may be destructive, up-regulation of others may result from increases in normal tissue turnover. The production of MMP-2 and MMP-9 by the anabolic transforming growth factor beta-1 (TGF-beta1) in normal equine chondrocytes was investigated.

DESIGN

Equine chondrocytes from clinically normal femoropatellar joints were maintained in alginate beads. After serum deprivation, cells were exposed to TGF-beta1 at several concentrations for varying times. Activities of MMP-2 and MMP-9 were estimated by gelatin zymography, while mRNA for MMP-2, MMP-9 and collagen type II were detected using reverse transcription-polymerase chain reaction.

RESULTS

Stimulation with TGF-beta1 differentially regulated MMP-2 and MMP-9, with strong up-regulation of both MMP-9 mRNA and enzyme. Increases in MMP-9 enzyme were dose-dependent (0-49 h). There is some evidence suggesting a slight reduction in MMP-2 release following stimulation. Collagen type II mRNA was transiently increased following stimulation.

CONCLUSIONS

The different effects of TGF-beta1 on MMP-2 and MMP-9 production by normal chondrocytes suggests different roles for these enzymes. The increases in both MMP-9 and collagen type II mRNA following stimulation may suggest a role for MMP-9 in tissue maintenance. Therefore, increased MMP-9 may be secondary to, as distinct from a cause of, cartilage damage.

Immunological and inflammatory characterisation of three canine cell lines: K1, K6 and DH82

Three canine cell lines, K1, K6 and DH82, derived from canine malignant neoplasms, were characterised. They were examined for expression of surface antigens, cytokines, neuropeptide receptors, matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). The growth characteristics of the cell lines were established and bioassays used to detect production of TNF-alpha, IL-1 and IL-6. In the DH82 cell line, production of TNF-alpha and IL-6 was readily detected. Neither K1 or K6 cell lines produced any measurable amounts of TNF-alpha, IL-1 or IL-6. At a molecular level, using reverse transcription-polymerase chain reaction (RT-PCR) to detect specific mRNA, the DH82 cell line expressed TNF-alpha, IL-1 and IL-6, whereas the K1 and K6 cell lines expressed TNF-alpha. Canine IL-5, IL-8 and IL-10 mRNA were detected in the DH82 cell line but only IL-5 and IL-8 mRNA were detected in the K1 and K6 cell lines. Gelatin zymography was used for the detection of MMP-2 and MMP-9 and all three cell lines produced MMP-2 but only the DH82 cell line produced MMP-9. Reverse zymography was used to detect TIMP-1 and TIMP-2 and all three cell lines produced both proteins. The presence of these MMPs and TIMPs was confirmed at a molecular level using RT-PCR. Canine MMP-14 mRNA was detected in all three cell lines. For this investigation several genes for canine inflammatory molecules were cloned and sequenced for molecular detection; these included IL-1, IL-6, IL-8, TNF-alpha, MMP-9, MMP-14, TIMP-1, TIMP-2 and beta-actin. Of all the cell surface antigens tested, only CD14 was expressed on the DH82 cell line although CD5 and CD45 was partially expressed. The K1 and K6 cell lines were negative for all of the CD markers tested. K1 and K6 were negative for Neurokinin 1 receptor (NK1-R) but positive for Calcitonin gene related peptide receptor type 1 (CGRP-1R) and Calcitonin gene related peptide receptor component protein (CGRP-RCP). The DH82 cell line expressed neither NK1-R or CGRP-1R; however, it did express CGRP-RCP. Generally the DH82 cell line exhibited considerable similarity to canine monocytes, but all three cell lines will be useful as standards and for the purification of various immunological and inflammatory mediators in the dog.